Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

AI Partnership Looks to Rapidly Advance Cancer Diagnosis

By Author Proscia | March 6, 2020

The University of California, San Francisco (UCSF) and digital pathology company Proscia have announced a partnership to advance artificial intelligence (AI) in interpreting pathology results in patients. The goal of this partnership is to increase the speed and accuracy at which cancer can be diagnosed.

As an early adopter of digital pathology, UCSF has amassed volumes of data that can be used by Proscia to ensure its computational application surmounts the obstacles involved in creating AI software in a clinical, commercial application.

Our website uses cookies. By using this site, you agree to its use of cookies.